|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2002-9-19
|
|
pubmed:abstractText |
The adenosine A2A agonist ATL-146e ameliorates reperfusion inflammation, reducing subsequent paralysis and neuronal apoptosis after spinal cord ischemia. We hypothesized that neuroprotection with ATL-146e involves inducible neuronal adenosine A2A receptors (A2A-R) that are upregulated after ischemia.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0003-4975
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
74
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
846-9; discussion 849-50
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:12238849-Animals,
pubmed-meshheading:12238849-Cyclohexanecarboxylic Acids,
pubmed-meshheading:12238849-Motor Neurons,
pubmed-meshheading:12238849-Neuroprotective Agents,
pubmed-meshheading:12238849-Paralysis,
pubmed-meshheading:12238849-Purinergic P1 Receptor Agonists,
pubmed-meshheading:12238849-Purines,
pubmed-meshheading:12238849-Rabbits,
pubmed-meshheading:12238849-Receptor, Adenosine A2A,
pubmed-meshheading:12238849-Receptors, Purinergic P1,
pubmed-meshheading:12238849-Spinal Cord,
pubmed-meshheading:12238849-Spinal Cord Ischemia,
pubmed-meshheading:12238849-Up-Regulation
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Adenosine A2A agonist reduces paralysis after spinal cord ischemia: correlation with A2A receptor expression on motor neurons.
|
|
pubmed:affiliation |
Division of Vascular and Endovascular Surgery, University of Tennessee Medical Center, Knoxville, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
